No description available.

no / Predictive toxicology is concerned with the development of models that are able to predict the toxicity of chemicals. A reliable prediction of toxic effects of chemicals in living systems is highly desirable in cosmetics, drug design or food protection to speed up the process of chemical compound discovery while reducing the need for lab tests. There is an extensive literature associated with the best practice of model generation and data integration but management and automated identification of relevant models from available collections of models is still an open problem. Currently, the decision on which model should be used for a new chemical compound is left to users. This paper intends to initiate the discussion on automated model identification. We present an algorithm, based on Pareto optimality, which mines model collections and identifies a model that offers a reliable prediction for a new chemical compound. The performance of this new approach is verified for two endpoints: IGC50 and LogP. The results show a great potential for automated model identification methods in predictive toxicology.

Para desenvolver um novo medicamento, pesquisadores devem analisar os alvos biológicos de uma dada doença, descobrir e desenvolver candidatos a fármacos para este alvo biológico, realizando em paralelo, testes em laboratório para validar a eficiência e os efeitos colaterais da substância química. O estudo quantitativo da relação estrutura-atividade (QSAR) envolve a construção de modelos de regressão que relacionam um conjunto de descritores de um composto químico e a sua atividade biológica com relação a um ou mais alvos no organismo. Os conjuntos de dados manipulados pelos pesquisadores para análise QSAR são caracterizados geralmente por um número pequeno de instâncias e isso torna mais complexa a construção de modelos preditivos. Nesse contexto, a transferência de conhecimento utilizando informações de outros modelos QSAR\'s com mais dados disponíveis para o mesmo alvo biológico seria desejável, diminuindo o esforço e o custo do processo para gerar novos modelos de descritores de compostos químicos. Este trabalho apresenta uma abordagem de transferência de aprendizagem indutiva (por parâmetros), tal proposta baseia-se em uma variação do método de Regressão por Vetores Suporte adaptado para transferência de aprendizagem, a qual é alcançada ao aproximar os modelos gerados separadamente para cada tarefa em questão. Considera-se também um método de transferência de aprendizagem por instâncias, denominado de TrAdaBoost. Resultados experimentais mostram que as abordagens de transferência de aprendizagem apresentam bom desempenho quando aplicadas a conjuntos de dados de benchmark e a conjuntos de dados químicos / To develop a new medicament, researches must analyze the biological targets of a given disease, discover and develop drug candidates for this biological target, performing in parallel, biological tests in laboratory to validate the effectiveness and side effects of the chemical substance. The quantitative study of structure-activity relationship (QSAR) involves building regression models that relate a set of descriptors of a chemical compound and its biological activity with respect to one or more targets in the organism. Datasets manipulated by researchers to QSAR analysis are generally characterized by a small number of instances and this makes it more complex to build predictive models. In this context, the transfer of knowledge using information other\'s QSAR models with more data available to the same biological target would be desirable, nince its reduces the effort and cost to generate models of chemical descriptors. This work presents an inductive learning transfer approach (by parameters), such proposal is based on a variation of the Vector Regression method Adapted support for learning transfer, which is achieved by approaching the separately generated models for each task. It is also considered a method of learning transfer by instances, called TrAdaBoost. Experimental results show that learning transfer approaches perform well when applied to some datasets of benchmark and dataset chemical

Para desenvolver um novo medicamento, pesquisadores devem analisar os alvos biológicos de uma dada doença, descobrir e desenvolver candidatos a fármacos para este alvo biológico, realizando em paralelo, testes em laboratório para validar a eficiência e os efeitos colaterais da substância química. O estudo quantitativo da relação estrutura-atividade (QSAR) envolve a construção de modelos de regressão que relacionam um conjunto de descritores de um composto químico e a sua atividade biológica com relação a um ou mais alvos no organismo. Os conjuntos de dados manipulados pelos pesquisadores para análise QSAR são caracterizados geralmente por um número pequeno de instâncias e isso torna mais complexa a construção de modelos preditivos. Nesse contexto, a transferência de conhecimento utilizando informações de outros modelos QSAR\'s com mais dados disponíveis para o mesmo alvo biológico seria desejável, diminuindo o esforço e o custo do processo para gerar novos modelos de descritores de compostos químicos. Este trabalho apresenta uma abordagem de transferência de aprendizagem indutiva (por parâmetros), tal proposta baseia-se em uma variação do método de Regressão por Vetores Suporte adaptado para transferência de aprendizagem, a qual é alcançada ao aproximar os modelos gerados separadamente para cada tarefa em questão. Considera-se também um método de transferência de aprendizagem por instâncias, denominado de TrAdaBoost. Resultados experimentais mostram que as abordagens de transferência de aprendizagem apresentam bom desempenho quando aplicadas a conjuntos de dados de benchmark e a conjuntos de dados químicos / To develop a new medicament, researches must analyze the biological targets of a given disease, discover and develop drug candidates for this biological target, performing in parallel, biological tests in laboratory to validate the effectiveness and side effects of the chemical substance. The quantitative study of structure-activity relationship (QSAR) involves building regression models that relate a set of descriptors of a chemical compound and its biological activity with respect to one or more targets in the organism. Datasets manipulated by researchers to QSAR analysis are generally characterized by a small number of instances and this makes it more complex to build predictive models. In this context, the transfer of knowledge using information other\'s QSAR models with more data available to the same biological target would be desirable, nince its reduces the effort and cost to generate models of chemical descriptors. This work presents an inductive learning transfer approach (by parameters), such proposal is based on a variation of the Vector Regression method Adapted support for learning transfer, which is achieved by approaching the separately generated models for each task. It is also considered a method of learning transfer by instances, called TrAdaBoost. Experimental results show that learning transfer approaches perform well when applied to some datasets of benchmark and dataset chemical

Computational drug design methods have great potential in drug discovery particularly in lead identification and lead optimization. 3-Phosphoinositide dependent kinase-1 (PDK1) is a protein kinase and a well validated anti-cancer target. Inhibitors of PDK1 have the potential to be developed as anti-cancer drugs. In this work, we have applied various novel computational drug design strategies to design and identify new PDK1 inhibitors with potential anti-cancer activity. We have pursued novel structure-based drug design strategies and identified a new binding mode for celecoxib and its derivatives binding with PDK1. This new binding mode provides a valuable basis for rational design of potent PDK1 inhibitors. In order to understand the structure-activity relationship of indolinone-based PDK1 inhibitors, we have carried out a combined molecular docking and three-dimensional quantitative structure-activity relationship (3D-QSAR) modeling study. The predictive ability of the developed 3D-QSAR models were validated using an external test set of compounds. An efficient strategy of the hierarchical virtual screening with increasing complexity was pursued to identify new hits against PDK1. Our approach uses a combination of ligand-based and structure-based virtual screening including shape-based filtering, rigid docking, and flexible docking. In addition, a more sophisticated molecular dynamics/molecular mechanics- Poisson-Boltzmann surface area (MD/MM-PBSA) analysis was used as the final filter in the virtual screening. Our screening strategy has led to the identification of a new PDK1 inhibitor. The anticancer activities of this compound have been confirmed by the anticancer activity assays of national cancer institute-developmental therapeutics program (NCI-DTP) using 60 cancer cell lines. The PDK1-inhibitor binding mode determined in this study may be valuable in future de novo drug design. The virtual screening approach tested and used in this study could also be applied to lead identification in other drug discovery efforts.